126 related articles for article (PubMed ID: 38579430)
1. Systemic tolerance of intravenous milrinone administration for cerebral vasospasm secondary to non-traumatic subarachnoid hemorrhage.
Julian N; Gaugain S; Labeyrie MA; Barthélémy R; Froelich S; Houdart E; Mebazaa A; Chousterman BG
J Crit Care; 2024 Aug; 82():154807. PubMed ID: 38579430
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Steiger HJ; Ensner R; Andereggen L; Remonda L; Berberat J; Marbacher S
Acta Neurochir (Wien); 2022 Mar; 164(3):811-821. PubMed ID: 35138488
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone.
Schmidt U; Bittner E; Pivi S; Marota JJ
Anesth Analg; 2010 Mar; 110(3):895-902. PubMed ID: 20185665
[TBL] [Abstract][Full Text] [Related]
4. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Fraticelli AT; Cholley BP; Losser MR; Saint Maurice JP; Payen D
Stroke; 2008 Mar; 39(3):893-8. PubMed ID: 18239182
[TBL] [Abstract][Full Text] [Related]
5. Which Protocol for Milrinone to Treat Cerebral Vasospasm Associated With Subarachnoid Hemorrhage?
Crespy T; Heintzelmann M; Chiron C; Vinclair M; Tahon F; Francony G; Payen JF
J Neurosurg Anesthesiol; 2019 Jul; 31(3):323-329. PubMed ID: 30015694
[TBL] [Abstract][Full Text] [Related]
6. A Phase I proof-of-concept and safety trial of sildenafil to treat cerebral vasospasm following subarachnoid hemorrhage.
Washington CW; Derdeyn CP; Dhar R; Arias EJ; Chicoine MR; Cross DT; Dacey RG; Han BH; Moran CJ; Rich KM; Vellimana AK; Zipfel GJ
J Neurosurg; 2016 Feb; 124(2):318-27. PubMed ID: 26314998
[TBL] [Abstract][Full Text] [Related]
7. Effect of intrathecal milrinone injection via lumbar catheter on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Koyanagi M; Fukuda H; Lo B; Uezato M; Kurosaki Y; Sadamasa N; Handa A; Chin M; Yamagata S
J Neurosurg; 2018 Mar; 128(3):717-722. PubMed ID: 28298035
[TBL] [Abstract][Full Text] [Related]
8. Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia.
Abulhasan YB; Ortiz Jimenez J; Teitelbaum J; Simoneau G; Angle MR
J Neurosurg; 2020 Mar; 134(3):971-982. PubMed ID: 32217799
[TBL] [Abstract][Full Text] [Related]
9. Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm.
Duman E; Karakoç F; Pinar HU; Dogan R; Fırat A; Yıldırım E
Interv Neuroradiol; 2017 Dec; 23(6):636-643. PubMed ID: 28956512
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Milrinone for Cerebral Vasospasm in Subarachnoid Hemorrhage: The MILRISPASM Controlled Before-After Study.
Lakhal K; Hivert A; Alexandre PL; Fresco M; Robert-Edan V; Rodie-Talbere PA; Ambrosi X; Bourcier R; Rozec B; Cadiet J
Neurocrit Care; 2021 Dec; 35(3):669-679. PubMed ID: 34478028
[TBL] [Abstract][Full Text] [Related]
11. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
12. Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital protocol.
Lannes M; Teitelbaum J; del Pilar Cortés M; Cardoso M; Angle M
Neurocrit Care; 2012 Jun; 16(3):354-62. PubMed ID: 22528278
[TBL] [Abstract][Full Text] [Related]
13. Milrinone via lumbar subarachnoid catheter for vasospasm after aneurysmal subarachnoid hemorrhage.
Sadamasa N; Yoshida K; Narumi O; Chin M; Yamagata S
Neurocrit Care; 2014 Dec; 21(3):470-5. PubMed ID: 24899113
[TBL] [Abstract][Full Text] [Related]
14. Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage.
Shankar JJ; dos Santos MP; Deus-Silva L; Lum C
Neuroradiology; 2011 Feb; 53(2):123-8. PubMed ID: 20549498
[TBL] [Abstract][Full Text] [Related]
15. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
[TBL] [Abstract][Full Text] [Related]
16. Continuous intra-arterial dilatation with nimodipine and milrinone for refractory cerebral vasospasm.
Anand S; Goel G; Gupta V
J Neurosurg Anesthesiol; 2014 Jan; 26(1):92-3. PubMed ID: 23774116
[No Abstract] [Full Text] [Related]
17. Kinetics of cerebral blood flow velocities during treatment for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.
Rouanet C; Chaddad F; Freitas F; Miranda M; Vasconcellos N; Valiente R; Muehlschlegel S; Silva GS
Neurocrit Care; 2022 Feb; 36(1):226-239. PubMed ID: 34286467
[TBL] [Abstract][Full Text] [Related]
18. CT perfusion-guided administration of IV milrinone is associated with a reduction in delayed cerebral infarction after subarachnoid hemorrhage.
Szabo V; Baccialone S; Kucharczak F; Dargazanli C; Garnier O; Pavillard F; Molinari N; Costalat V; Perrigault PF; Chalard K
Sci Rep; 2024 Jun; 14(1):14856. PubMed ID: 38937568
[TBL] [Abstract][Full Text] [Related]
19. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases.
Arakawa Y; Kikuta K; Hojo M; Goto Y; Ishii A; Yamagata S
Neurosurgery; 2001 Apr; 48(4):723-8; discussion 728-30. PubMed ID: 11322432
[TBL] [Abstract][Full Text] [Related]
20. [Effect of magnesium sulphate and milrinone on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a randomized study].
Soliman R; Zohry G
Braz J Anesthesiol; 2019; 69(1):64-71. PubMed ID: 30409409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
